Table 3.
Prognosis studies of circRNA and pancreatic cancer.
| first author | publish yearar | country | ethnicity | cancer type | circRNA type | expression | specimen source | high expression |
low expression |
follow-up time (month) | OS(HR) | LL | UL | DFS(HR) | LL | UL | NOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shangyou Zheng | 2022 | China | Asian | PDAC | Circ-CUL2 | U | tissue | 80 | 81 | 80 | 2.374 | 1.645 | 3.426 | 2.073 | 1.460 | 2.942 | 6 | high/low |
| Lingdong Meng | 2022 | China | Asian | PDAC | Circ-STX6 | U | tissue | 48 | 49 | 80 | 3.013 | 1.655 | 5.486 | 7 | high/low | |||
| Zhiwei He | 2022 | China | Asian | PC | Circ-ATG7 | U | tissue | 46 | 46 | 60 | 1.840 | 1.150 | 2.950 | 6 | high/low | |||
| Xiaowei Fu | 2022 | China | Asian | PC | Hsa_circ_0046523 | U | tissue | 29 | 28 | 60 | 1.890 | 1.050 | 3.420 | 7 | high/low | |||
| Chonghui Hu | 2022 | China | Asian | PDAC | Circ-FARP1 | U | tissue | 41 | 41 | 20 | 2.790 | 1.700 | 4.570 | 7 | high/low | |||
| Yun Chen1 | 2022 | China | Asian | PC | Has_circ_0141633 | U | plasma | 48 | 49 | 60 | 2.740 | 1.220 | 4.130 | 7 | high/low | |||
| Yun Chen2 | 2022 | China | Asian | PC | Has_circ_0008234 | U | plasma | 48 | 49 | 60 | 2.400 | 1.050 | 3.460 | 7 | high/low | |||
| Siqiao Li | 2021 | China | Asian | PC | Circ-MFN2 | U | plasma | 48 | 7 | 60 | 2.457 | 1.489 | 8.749 | 6 | high/low | |||
| Xianbo Shen | 2021 | China | Asian | PC | Hsa_circ_001569 | U | plasma | 13 | 13 | 60 | 2.256 | 1.132 | 4.836 | 6 | high/low | |||
| Ji-Ping Hou | 2021 | China | Asian | PC | Circ-CCT3 | U | tissue | 15 | 15 | 60 | 2.940 | 1.850 | 6.160 | 6 | high/low | |||
| Xu Han | 2021 | China | Asian | PDAC | Hsa_circ_0071036 | U | tissue | 90 | 90 | 24 | 3.700 | 1.300 | 10.500 | 7 | high/low | |||
| Jie Zhang | 2021 | China | Asian | PC | Hsa_circ_0066147 | U | tissue | 24 | 21 | 60 | 1.890 | 1.010 | 3.540 | 8 | high/low | |||
| Taoyue Yang | 2021 | China | Asian | PDAC | Circ-RHOBTB3 | U | tissue | 55 | 55 | 80 | 1.550 | 1.010 | 2.450 | 7 | high/low | |||
| Zeyin Rong | 2021 | China | Asian | PDAC | Circ-EYA3 | U | tissue | 138 | 71 | 70 | 1.530 | 1.030 | 2.260 | 6 | high/low | |||
| Gang Ma | 2021 | China | Asian | PDAC | Hsa_circ-0005105 | U | tissue | 38 | 37 | 60 | 2.650 | 1.360 | 5.150 | 1.840 | 1.130 | 2.980 | 7 | high/low |
| XiuminLiu | 2021 | China | Asian | PDAC | Hsa_circ_00684 | U | tissue | 40 | 40 | 40 | 1.700 | 1.010 | 2.860 | 7 | high/low | |||
| Yuting Li | 2020 | China | Asian | PDAC | Circ-PCAC1 | U | Tissue | 38 | 38 | 60 | 1.733 | 1.066 | 2.991 | 1.636 | 1.090 | 2.811 | 6 | high/low |
| Y.-S. HOU | 2020 | China | Asian | PC | Hsa_circ_0005273 | U | tissue | 23 | 33 | 80 | 2.450 | 1.060 | 7.850 | 1.220 | 1.040 | 3.390 | 8 | high/low |
| Guo, X. | 2020 | China | Asina | PDAC | Circ-BFAR | U | tissue | 104 | 104 | 60 | 1.658 | 1.213 | 2.267 | 1.620 | 1.183 | 2.217 | 8 | high/low |
| YiXu | 2019 | China | Asian | PDAC | Hsa_circ_0030235 | U | tissue | 32 | 30 | 60 | 2.626 | 1.264 | 5.455 | 7 | high/low | |||
| Liguo Hao | 2019 | China | Asian | PDAC | Hsa_circ_0007534 | U | tissue | 30 | 30 | 60 | 2.135 | 1.217 | 3.745 | 6 | high/low | |||
| Yan Chen | 2019 | China | Asian | PDAC | Circ-ASH2L | U | tissue | 45 | 45 | 50 | 1.741 | 1.075 | 2.821 | 6 | high/low | |||
| Zhonghu Li | 2019 | China | Asian | PDAC | Circ-PDE8 | U | tissue | 46 | 47 | 50 | 1.764 | 1.064 | 2.925 | 7 | high/low | |||
| Jie Li | 2018 | China | Asian | PDAC | Circ-IRAS | U | tissue | 42 | 43 | 50 | 1.749 | 1.047 | 2.924 | 7 | high/low | |||
| YuehongJiang | 2018 | China | Asian | PDAC | Hsa_circ_0001649 | D | tissue | 25 | 33 | 60 | 1.993 | 1.035 | 3.837 | 7 | high/low |